CNBC's Meg Tirrell speaks to Dr. George Scangos, Biogen Idec CEO, about the company's Q2 earnings surge, drug pipeline, and America's tax code. Scangos says we need a corporate tax rate that is competitive with rest of the world and a territorial tax system.
CNBC's David Faber reports Puma Biotechnology surges on positive results for a breast cancer drug.
Puma Biotechnology's experimental breast cancer drug met its main goal in a late-stage trial, but the options market is sensing something funky.
July 22- Puma Biotechnology Inc said its experimental breast cancer drug met its main goal in a late-stage trial. Shares of the company, which doesn't have any drug in the market, tripled to $176.94 in extended trading.
NEW YORK— Activist investor Bill Ackman fired his latest salvo at the weight loss and nutritional supplements company Herbalife on Tuesday, alleging that one of the business models used by its distributors is evidence that the company operates as an illegal pyramid scheme.
There is more good news about HIV treatment pills used to prevent infection in people at high risk of getting the AIDS virus: Follow-up from a landmark study that proved the drug works now shows that it does not encourage risky sex and is effective even if people skip some doses.
Lacey Spears, of Scottsville, Kentucky, has pleaded not guilty to charges of depraved murder and manslaughter in the January death of her son, Garnett-Paul Spears, whose sodium levels rose to an extremely dangerous level with no medical explanation.
CNBC's Scott Cohn reports FedEx has been indicted on 15 criminal counts for helping Internet pharmacies deliver drugs to buyers in the U.S. without prescriptions.
In both cases, they said, a person infected with the virus after visiting the Caribbean was then bitten again by an uninfected mosquito in Florida, which then transmitted the illness further.
New details from two studies reveal more side effects from niacin, a drug that hundreds of thousands of Americans take for cholesterol problems and general heart health. Some prominent doctors say the drug now seems too risky for routine use. Those details are in this week's New England Journal of Medicine.
"The reasons why these samples went unnoticed for this long is something we're actively trying to understand," said FDA deputy director for biologics Dr.
ZURICH, July 16- Roche's experimental drug crenezumab failed to delay a decline in thinking and memory skills in people with Alzheimer's disease, a result likely to bolster a growing belief that drugs need to be given in earlier stages of the disease to show a benefit.
ZURICH, July 16- Roche said its experimental Alzheimer's drug failed to meet its main goals in a mid-stage study, a result likely to bolster the belief that drugs need to be given in earlier stages of the disease to slow patients' decline.
Jeffrey Cummings of the Cleveland Clinic said none of the deaths seemed due to the drug and pneumonia occurred at a rate to be expected in older people. Results were revealed Wednesday at the Alzheimer's Association International Conference in Copenhagen.
July 16- Pfizer Inc said a once-weekly dose of its drug, already approved for on-demand treatment of a blood clotting disorder, reduced bleeding rates in patients in a late-stage study.
Republicans blocked a bill that was designed to override a Supreme Court ruling and ensure access to contraception for women who get their health insurance from companies with religious objections. But Democrats hope the issue has enough life to energize female voters in the fall, when Republicans are threatening to take control of the Senate.
DAPU, China, July 16- After a test showed farmer Zhao Heping's toddler grandson had high levels of lead in his blood two years ago, local officials in China's Hunan province offered the child medicine, he says- and milk.
CNBC's Meg Tirrell reports which biotech companies are working on what analysts say could be the next big biotech catalyst known as NASH, or nonalcoholic steatohepatitis.
Hundreds have died in West Africa from the Ebola virus. With no known cure and a high mortality rate, alarm is real.
Most millennials use alternative medicine to maintain wellbeing rather than cure existing sicknesses. The Fiscal Times reports.